CD73 polymorphisms are associated with schizophrenia
- PMID: 38758511
- DOI: 10.1007/s11302-024-10004-3
CD73 polymorphisms are associated with schizophrenia
Abstract
Ecto-5'-nucleotidase/CD73 enzyme plays a key role in the regulation of extracellular adenosine levels, thereby exerting influence on adenosine homeostasis. Emerging evidence suggests that perturbations in purines and ecto-5'-nucleotidase activity are associated with an augmented susceptibility to schizophrenia. However, the precise impact of genetic variations in CD73 on individuals with schizophrenia remains poorly understood. Here, our study demonstrated that rs3734442 allele and rs4431401 heterozygote were conferred a significant risk of schizophrenia disease (rs3734442: odds ratio, 0.556; 95% CI, 0.375 to 0.825; p = 0.004; rs4431401: odds ratio, 1.881, 95% CI, 1.117 to 3.166; p = 0.020). Comparing different genders, we observed a significant association between rs3734442 genotypes and male cases (rs3734442: odds ratio, 0.452; 95% CI, 0.257 to 0.796; p = 0.007). Likewise, there was a significant association between rs4431401 genotypes and male patients (rs4431401: odds ratio, 2.570; 95% CI, 1.196 to 5.522; p = 0.015). Based on family history and antipsychotics medication usage, our data reveals that the rs9444348 allele exhibits the most significant association with familial susceptibility to schizophrenia (odds ratio, 1.541; 95% CI, 1.009 to 2.353; p = 0.048 for A vs G). Moreover, individuals carrying variants of rs6922, rs2229523, and rs2065114 while being treated with clozapine demonstrate a higher frequency proportion compared to those receiving risperidone treatment (p = 0.035; p = 0.049; p = 0.027 respectively). Additionally, our results indicate that patients with GG genotype of rs9444348 had significantly higher likelihood of using clozapine instead of sulpiride (p = 0.048). Overall, our data strongly suggest that genetic variations in CD73 are significantly associated with schizophrenia risk and may serve as valuable resources for identifying therapeutic targets.
Keywords: CD73; Ecto-5’-nucleotidase; Schizophrenia; Single-nucleotide polymorphism.
© 2024. The Author(s).
Similar articles
-
Association of the ADORA2A receptor and CD73 polymorphisms with epilepsy.Front Pharmacol. 2023 Mar 29;14:1152667. doi: 10.3389/fphar.2023.1152667. eCollection 2023. Front Pharmacol. 2023. PMID: 37063258 Free PMC article.
-
Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis Registry.PLoS One. 2017 Feb 17;12(2):e0172407. doi: 10.1371/journal.pone.0172407. eCollection 2017. PLoS One. 2017. PMID: 28212442 Free PMC article.
-
Correlation Between Single-Nucleotide Polymorphisms Within miR-30a and Related Target Genes and Risk or Prognosis of Nephrotic Syndrome.DNA Cell Biol. 2018 Mar;37(3):233-243. doi: 10.1089/dna.2017.4024. Epub 2018 Jan 22. DNA Cell Biol. 2018. PMID: 29356585
-
The role of ecto-5'-nucleotidase in endothelial dysfunction and vascular pathologies.Pharmacol Rep. 2015 Aug;67(4):675-81. doi: 10.1016/j.pharep.2015.05.002. Epub 2015 May 16. Pharmacol Rep. 2015. PMID: 26321267 Review.
-
The elegant complexity of mammalian ecto-5'-nucleotidase (CD73).Trends Cell Biol. 2021 Oct;31(10):829-842. doi: 10.1016/j.tcb.2021.05.008. Epub 2021 Jun 8. Trends Cell Biol. 2021. PMID: 34116887 Free PMC article. Review.
References
-
- Singh T, Poterba T, Curtis D et al (2022) Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature 604(7906):509–516. https://doi.org/10.1038/s41586-02204556-w - DOI - PubMed - PMC
-
- Owen MJ, Sawa A, Mortensen PB (2016) Schizophrenia Lancet 388(10039):86–97. https://doi.org/10.1016/S0140-6736(15)01121-6 - DOI - PubMed
-
- Schizophrenia (2015) Nat Rev Dis Primers 1:15069. Published 2015 Nov 12. https://doi.org/10.1038/nrdp.2015.69
-
- Fleischhacker WW, Arango C, Arteel P et al (2014) Schizophrenia–time to commit to policychange. Schizophr Bull. 40 Suppl 3(Suppl 3):S165–S194. https://doi.org/10.1093/schbul/sbu006 - DOI - PubMed
-
- van Os J, Kapur S (2009) Schizophrenia Lancet 374(9690):635–645. https://doi.org/10.1016/S0140-6736(09)60995-8 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials